Originally Posted by
kiwidollabill
^From a product perspective there is some clear differences between the two which can be argued - cytology vs non-invasive, antigen vs genetic etc..... and I dont think this would be the basis on which company becomes more successful (or cash +ve first).
From a strategic perspective there ARE major differences around how they are looking to commercialise their product and (I would argue) will judge their sucess - direct sales vs distribution network, manufacturer of kit vs lab company